Both in Biotechnology
Metagenomi Therapeutics vs Aligos Therapeutics
Over the past year MGX returned −67.7% and ALGS returned −38.5%; their daily moves had a correlation of 0.30.
MGX −67.7% ALGS −38.5%Growth of $1, one year, split-adjusted
| Metric | MGX | ALGS |
|---|---|---|
| Price | $0.7308 | $4.51 |
| Market cap | $27.6M | $28.2M |
| Today | −7.49% | −10.16% |
| 1 month | −25.8% | −15.2% |
| 6 months | −48.5% | −25.2% |
| Year to date | −54.9% | −51.6% |
| 1 year | −68.1% | −37.4% |
| Revenue growth (YoY) | −103.0% | +2778.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −5.4% |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | 0.9× |
| Net cash | $120.7M | $30.3M |
| Dividend yield | — | — |
| Volatility (60d) | 49.8% | 68.5% |
| Short % of float | 5.2% | 12.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).